Geneva Partners LLC trimmed its position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 29.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 26,391 shares of the company's stock after selling 10,774 shares during the period. Ryan Specialty comprises 1.0% of Geneva Partners LLC's portfolio, making the stock its 29th largest position. Geneva Partners LLC's holdings in Ryan Specialty were worth $1,949,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. GAMMA Investing LLC increased its position in shares of Ryan Specialty by 21.8% during the first quarter. GAMMA Investing LLC now owns 2,101 shares of the company's stock valued at $155,000 after buying an additional 376 shares during the period. CIBC Private Wealth Group LLC increased its position in shares of Ryan Specialty by 6,911.0% during the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock valued at $48,036,000 after buying an additional 774,718 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of Ryan Specialty by 3.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,215 shares of the company's stock valued at $902,000 after buying an additional 460 shares during the period. Jones Financial Companies Lllp increased its position in shares of Ryan Specialty by 982.1% during the fourth quarter. Jones Financial Companies Lllp now owns 1,450 shares of the company's stock valued at $93,000 after buying an additional 1,316 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in shares of Ryan Specialty by 3.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 974,451 shares of the company's stock valued at $62,521,000 after buying an additional 36,264 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.
Insider Transactions at Ryan Specialty
In related news, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the transaction, the executive vice president directly owned 1,117 shares of the company's stock, valued at approximately $73,543.28. The trade was a 92.79% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total transaction of $354,000.00. Following the sale, the director owned 71,467 shares of the company's stock, valued at $5,059,863.60. The trade was a 6.54% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by insiders.
Ryan Specialty Price Performance
Shares of NYSE:RYAN traded down $0.42 on Tuesday, reaching $65.96. The company's stock had a trading volume of 946,917 shares, compared to its average volume of 919,492. Ryan Specialty Holdings Inc. has a 52-week low of $55.67 and a 52-week high of $77.16. The company has a market cap of $17.31 billion, a P/E ratio of 194.00, a PEG ratio of 1.78 and a beta of 0.66. The company has a 50-day simple moving average of $68.10 and a 200 day simple moving average of $68.14. The company has a debt-to-equity ratio of 3.45, a quick ratio of 1.05 and a current ratio of 1.05.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a net margin of 6.97% and a return on equity of 47.70%. The firm had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. During the same period in the previous year, the company earned $0.35 EPS. The firm's revenue for the quarter was up 25.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.73%. Ryan Specialty's dividend payout ratio is presently 141.18%.
Analyst Ratings Changes
A number of brokerages have weighed in on RYAN. Barclays cut their price objective on shares of Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a report on Monday. The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and increased their price target for the company from $74.00 to $81.00 in a report on Tuesday, May 13th. Wells Fargo & Company cut their price target on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Finally, Morgan Stanley raised their target price on shares of Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $75.25.
Check Out Our Latest Report on RYAN
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report